← FDA DRUG APPROVALS

FDA ANDA · ANDA064048

GENTAMICIN SULFATE

Sponsor: BAUSCH AND LOMB INC

APPLICATION
ANDA064048
TYPE
ANDA
ORIGINAL APPROVAL
1994-05-11
LATEST ACTION
2001-11-27
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

GENTAMICIN SULFATEPrescription
GENTAMICIN SULFATE EQ 0.3% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2001-11-27Manufacturing (CMC) · Supplement 14AP
2001-08-29Manufacturing (CMC) · Supplement 13AP
2001-03-07Manufacturing (CMC) · Supplement 12AP
2000-10-05Manufacturing (CMC) · Supplement 11AP
2000-06-27Manufacturing (CMC) · Supplement 10AP
2000-05-18Manufacturing (CMC) · Supplement 7AP
2000-05-15Manufacturing (CMC) · Supplement 9AP
2000-04-28Manufacturing (CMC) · Supplement 8AP
1999-06-07Manufacturing (CMC) · Supplement 6AP
1998-11-19Manufacturing (CMC) · Supplement 5AP
1998-05-04Manufacturing (CMC) · Supplement 4AP
1998-01-14Manufacturing (CMC) · Supplement 3AP
1996-08-26Manufacturing (CMC) · Supplement 2AP
1994-09-09Manufacturing (CMC) · Supplement 1AP
1994-05-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →